Insider Trading activities of Heska Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heska Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Heska Corp since year 2005. Table 2 shows the detailed insider transactions of Heska Corp since 2005. The reporting company's ticker symbol is HSKA. The reporting company's CIK number is 1038133.
The total value of stock buying since 2005 is $1,103,341.
The total value of stock sales since 2005 is $25,978,068.
The total value of stock option exercises since 2005 is $6,794,620.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Heska Corp (HSKA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 3,433 $348,130 2,608 $139,431
2017-06 0 $0 382 $38,224 382 $6,925
2017-05 1,000 $90,000 29,883 $2,945,378 32,290 $657,175
2017-04 0 $0 5,900 $607,681 0 $0
2017-03 0 $0 24,365 $2,234,564 15,865 $155,895
2017-01 0 $0 5,000 $373,450 0 $0
2016-11 1,750 $117,018 24,997 $1,558,079 123,016 $1,723,670
2016-09 0 $0 5,000 $262,700 0 $0
2016-08 0 $0 55,571 $2,744,621 4,698 $39,228
2016-07 0 $0 59,264 $2,439,713 0 $0
2016-06 0 $0 20,000 $734,800 0 $0
2016-05 0 $0 56,998 $2,069,859 20,998 $237,706
2016-04 0 $0 0 $0 1,000 $4,400
2016-03 1,000 $32,490 0 $0 0 $0
2016-01 0 $0 15,000 $555,000 0 $0
2015-12 0 $0 9,700 $361,251 40,000 $491,900
2015-11 0 $0 15,499 $540,494 9,499 $118,737
2015-09 0 $0 1,699 $56,933 0 $0
2015-08 0 $0 65,747 $2,274,989 43,898 $530,617
2015-07 0 $0 6,534 $218,246 0 $0
2015-06 0 $0 33,609 $1,041,236 0 $0
2015-05 500 $14,525 12,682 $395,923 17,205 $148,184
2015-04 0 $0 10,000 $284,176 0 $0
2015-03 0 $0 17,765 $454,294 4,571 $50,281
2015-02 0 $0 0 $0 47,703 $462,880
2015-01 0 $0 0 $0 6,500 $57,200
2014-11 21,428 $299,992 49,927 $719,300 14,499 $126,591
2014-08 0 $0 14,600 $197,464 5,000 $23,000
2014-07 0 $0 0 $0 4,200 $33,600
2014-06 0 $0 936 $9,991 0 $0
2014-05 0 $0 4,200 $45,645 0 $0
2014-03 4,000 $42,930 7,000 $73,521 0 $0
2013-03 5,000 $41,682 0 $0 177 $1,493
2013-01 0 $0 0 $0 7,576 $53,050
2012-12 0 $0 0 $0 3,000 $10,200
2012-11 0 $0 1,000 $8,087 0 $0
2012-10 0 $0 49,381 $470,146 0 $0
2012-09 0 $0 0 $0 42,093 $240,968
2012-08 2,900 $23,075 0 $0 0 $0
2012-06 0 $0 0 $0 7,294 $44,639
2012-05 0 $0 0 $0 78,800 $645,361
2012-04 0 $0 0 $0 12,596 $126,085
2012-03 0 $0 0 $0 86,890 $466,356
2012-02 2,225 $20,927 200,000 $1,630,043 4,640 $25,705
2011-08 1,490 $14,767 0 $0 0 $0
2011-05 3,000 $25,896 0 $0 0 $0
2010-11 100,000 $43,954 0 $0 0 $0
2010-05 43,500 $32,095 0 $0 0 $0
2010-02 97,040 $66,353 0 $0 0 $0
2009-08 0 $0 7,790,466 $0 0 $0
2008-11 234,000 $64,363 0 $0 0 $0
2008-10 0 $0 0 $0 2,600 $1,118
2008-07 0 $0 0 $0 6,192 $6,891
2008-04 0 $0 0 $0 5,834 $8,751
2008-01 0 $0 0 $0 3,531 $6,249
2007-11 20,000 $40,650 0 $0 0 $0
2007-10 0 $0 0 $0 3,502 $6,268
2007-08 0 $0 4,090 $8,392 0 $0
2007-07 5,500 $10,986 0 $0 3,118 $6,348
2007-05 0 $0 53,717 $122,182 64,283 $69,990
2007-04 0 $0 0 $0 3,170 $5,078
2007-01 0 $0 0 $0 2,976 $4,999
2006-11 24,000 $40,185 0 $0 0 $0
2006-08 9,845 $13,951 0 $0 0 $0
2006-02 0 $0 0 $0 64,057 $57,651
2005-11 500 $595 118,120 $153,556 0 $0
2005-10 15,500 $15,831 0 $0 0 $0
2005-08 28,500 $21,360 0 $0 0 $0
2005-05 36,900 $29,716 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Heska Corp insiders (HSKA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-31 Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) Sale 825 102.21 84,326
2017-08-30 Mcmahon John (VP, Chief Financial Officer) Sale 2,608 101.15 263,804
2017-08-30 Mcmahon John (VP, Chief Financial Officer) Option Ex 2,608 53.46 139,431
2017-06-01 Asakowicz Steve (EVP, Comp. Animal Health Sales) Sale 382 100.06 38,224
2017-06-01 Asakowicz Steve (EVP, Comp. Animal Health Sales) Option Ex 382 18.13 6,925
2017-05-31 Lippincott Rod (EVP, Comp. Animal Health Sales) Sale 4,471 98.00 438,158
2017-05-31 Lippincott Rod (EVP, Comp. Animal Health Sales) Option Ex 4,471 50.79 227,082
2017-05-31 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 11,189 98.53 1,102,429
2017-05-26 Lippincott Rod (EVP, Comp. Animal Health Sales) Sale 6,756 98.03 662,256
2017-05-26 Lippincott Rod (EVP, Comp. Animal Health Sales) Option Ex 6,756 21.91 148,057
2017-05-24 Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) Sale 250 100.17 25,042
2017-05-24 Napolitano Jason A (COO, Chief Strategist and Sec.) Sale 5,000 100.50 502,500
2017-05-23 Mcmahon John (VP, Chief Financial Officer) Sale 587 97.00 56,937
2017-05-23 Mcmahon John (VP, Chief Financial Officer) Option Ex 417 34.08 14,209
2017-05-23 Wrenn Carol (Director) Sale 1,630 96.97 158,056
2017-05-23 Wrenn Carol (Director) Option Ex 1,630 8.10 13,203
2017-05-04 Larson Sharon J. (Director) Buy 1,000 90.00 90,000
2017-05-01 Gordon G Irwin (Director) Option Ex 19,016 13.39 254,624
2017-04-11 Napolitano Jason A (COO, Chief Strategist and Sec.) Sale 200 100.73 20,146
2017-04-10 Napolitano Jason A (COO, Chief Strategist and Sec.) Sale 4,800 103.19 494,399
2017-03-09 Lippincott Rod (EVP, Comp. Animal Health Sales) Sale 5,157 97.87 504,720
2017-03-09 Lippincott Rod (EVP, Comp. Animal Health Sales) Option Ex 5,157 11.28 58,170
2017-03-09 Mcmahon John (VP, Chief Financial Officer) Sale 708 97.42 68,973
2017-03-09 Mcmahon John (VP, Chief Financial Officer) Option Ex 708 34.08 24,125
2017-03-09 Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) Sale 500 96.64 48,321
2017-03-06 Wilson Kevin S. (CEO and President) Sale 8,000 90.00 720,000
2017-03-02 Eyl Steven M. (EVP, Global Sales & Marketing) Sale 10,000 89.25 892,550
2017-03-02 Eyl Steven M. (EVP, Global Sales & Marketing) Option Ex 10,000 7.36 73,600
2017-01-10 Napolitano Jason A (COO, Chief Strategist and Sec.) Sale 5,000 74.69 373,450
2016-11-29 Gordon G Irwin (Director) Sale 70 67.70 4,739
2016-11-28 Mcmahon John (VP, Chief Financial Officer) Sale 1,999 65.65 131,228
2016-11-28 Mcmahon John (VP, Chief Financial Officer) Option Ex 1,999 34.08 68,115
2016-11-28 Gordon G Irwin (Director) Sale 1,070 65.26 69,828
2016-11-25 Larson Sharon J. (Director) Buy 1,750 66.87 117,018
2016-11-25 Gordon G Irwin (Director) Sale 1,860 66.40 123,504
2016-11-22 Lippincott Rod (EVP, Comp. Animal Health Sales) Sale 5,000 64.85 324,260
2016-11-22 Lippincott Rod (EVP, Comp. Animal Health Sales) Option Ex 5,000 12.74 63,724
2016-11-15 Mcginley Michael J (Pres., Biologic. & Pharm.) Option Ex 1 17.17 17
2016-11-15 Napolitano Jason A (COO, Chief Strategist and Sec.) Option Ex 9,000 17.17 154,530
2016-11-11 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 96,016 13.51 1,297,464
2016-11-10 Wisnewski Nancy (EVP, Diag. Ops & Prod. Dev.) Option Ex 6,000 17.17 103,020
2016-11-07 Asakowicz Steve (EVP, Comp. Animal Health Sales) Sale 5,000 61.00 305,000
2016-11-07 Asakowicz Steve (EVP, Comp. Animal Health Sales) Option Ex 5,000 7.36 36,800
2016-11-07 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 9,998 59.96 599,520
2016-09-01 Napolitano Jason A (COO, CFO, EVP and Secretary) Sale 5,000 52.54 262,700
2016-08-29 Wilson Kevin S. (CEO and President) Sale 13,668 51.87 708,918
2016-08-26 Wilson Kevin S. (CEO and President) Sale 6,332 51.60 326,731
2016-08-24 Mcmahon John (VP, Fin. Oper. & Controller) Sale 137 51.30 7,028
2016-08-09 Asakowicz Steve (EVP, Comp. Animal Health Sales) Sale 4,698 52.55 246,865
2016-08-09 Asakowicz Steve (EVP, Comp. Animal Health Sales) Option Ex 4,698 8.35 39,228
2016-08-03 Wilson Kevin S. (CEO and President) Sale 30,720 47.34 1,454,376
2016-08-02 Wilson Kevin S. (CEO and President) Sale 16 43.95 703
2016-07-29 Wilson Kevin S. (CEO and President) Sale 20 43.95 879
2016-07-20 Wilson Kevin S. (CEO and President) Sale 3,779 44.02 166,362
2016-07-18 Wilson Kevin S. (CEO and President) Sale 5,465 44.31 242,132
2016-07-08 Wilson Kevin S. (CEO and President) Sale 10,000 42.37 423,670
2016-07-07 Napolitano Jason A (COO, CFO, EVP and Secretary) Sale 20,000 41.00 820,000
2016-07-06 Wilson Kevin S. (CEO and President) Sale 5,960 40.27 240,009
2016-07-01 Wilson Kevin S. (CEO and President) Sale 14,040 38.94 546,661
2016-06-02 Wilson Kevin S. (CEO and President) Sale 20,000 36.74 734,800
2016-05-12 Wilson Kevin S. (CEO and President) Sale 5,000 38.50 192,500
2016-05-10 Wilson Kevin S. (CEO and President) Sale 15,000 36.88 553,125
2016-05-10 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 5,998 36.50 218,927
2016-05-10 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 5,998 14.22 85,291
2016-05-09 Wilson Kevin S. (CEO and President) Sale 9,718 35.60 345,960
2016-05-05 Wilson Kevin S. (CEO and President) Sale 1,282 35.67 45,727
2016-05-05 Riley Sharon L. (Director) Sale 15,000 35.66 534,870
2016-05-05 Riley Sharon L. (Director) Option Ex 15,000 10.16 152,415
2016-05-03 Napolitano Jason A (COO, CFO, EVP and Secretary) Sale 5,000 35.75 178,750
2016-04-25 Napolitano Jason A (COO, CFO, EVP and Secretary) Option Ex 1,000 4.40 4,400
2016-03-08 Riley Sharon L. (Director) Buy 1,000 32.49 32,490
2016-01-27 Napolitano Jason A (EVP, COO, CFO and Secretary) Sale 15,000 37.00 555,000
2015-12-29 Napolitano Jason A (EVP, COO, CFO and Secretary) Sale 3,700 40.07 148,251
2015-12-22 Napolitano Jason A (EVP, COO, CFO and Secretary) Option Ex 1,000 4.40 4,400
2015-12-15 Napolitano Jason A (EVP, COO, CFO and Secretary) Option Ex 26,000 12.50 325,000
2015-12-03 Wilson Kevin S. (CEO and President) Sale 4,400 35.50 156,200
2015-12-02 Wilson Kevin S. (CEO and President) Sale 1,600 35.50 56,800
2015-12-01 Wisnewski Nancy (EVP, Prod. Dev & Cust. Support) Option Ex 13,000 12.50 162,500
2015-11-25 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 958 33.62 32,210
2015-11-25 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 958 12.50 11,975
2015-11-24 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 1,427 33.35 47,594
2015-11-24 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 1,427 12.50 17,837
2015-11-18 Wilson Kevin S. (CEO and President) Sale 6,000 35.00 210,000
2015-11-17 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 7,114 35.24 250,690
2015-11-17 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 7,114 12.50 88,925
2015-09-11 Napolitano Jason A (Chief Financial Officer) Sale 1,699 33.51 56,933
2015-08-31 Napolitano Jason A (Chief Financial Officer) Sale 4,998 33.62 168,007
2015-08-31 Grieve Robert B (Executive Chair) Sale 9,798 33.75 330,682
2015-08-31 Grieve Robert B (Executive Chair) Option Ex 9,798 12.50 122,475
2015-08-28 Grieve Robert B (Executive Chair) Sale 1,300 33.95 44,135
2015-08-28 Grieve Robert B (Executive Chair) Option Ex 1,300 12.50 16,250
2015-08-27 Grieve Robert B (Executive Chair) Sale 3,604 33.83 121,930
2015-08-27 Grieve Robert B (Executive Chair) Option Ex 3,604 12.50 45,050
2015-08-17 Wilson Kevin S. (CEO and President) Sale 2,498 34.91 87,210
2015-08-17 Grieve Robert B (Executive Chair) Sale 8,033 34.95 280,745
2015-08-17 Grieve Robert B (Executive Chair) Option Ex 8,033 12.50 100,412
2015-08-14 Wilson Kevin S. (CEO and President) Sale 200 34.94 6,988
2015-08-14 Lippincott Rod (EVP, Companion Animal Sales) Sale 3,898 34.26 133,553
2015-08-14 Lippincott Rod (EVP, Companion Animal Sales) Option Ex 3,898 7.86 30,618
2015-08-13 Wilson Kevin S. (CEO and President) Sale 1,901 34.90 66,344
2015-08-11 Wilson Kevin S. (CEO and President) Sale 2,763 35.19 97,229
2015-08-11 Napolitano Jason A (Chief Financial Officer) Sale 3,301 35.58 117,442
2015-08-11 Grieve Robert B (Executive Chair) Sale 1,106 35.00 38,714
2015-08-11 Grieve Robert B (Executive Chair) Option Ex 1,106 12.50 13,825
2015-08-10 Wilson Kevin S. (CEO and President) Sale 2,638 35.02 92,382
2015-08-10 Grieve Robert B (Executive Chair) Sale 18,659 34.99 652,878
2015-08-10 Grieve Robert B (Executive Chair) Option Ex 16,159 12.50 201,987
2015-08-04 Grieve Robert B (Executive Chair) Sale 1,050 35.00 36,750
2015-07-30 Napolitano Jason A (Chief Financial Officer) Sale 5,534 34.02 188,261
2015-07-13 Grieve Robert B (Executive Chair) Sale 1,000 29.98 29,985
2015-06-08 Wilson Kevin S. (CEO and President) Sale 11,810 30.16 356,236
2015-06-03 Grieve Robert B (Executive Chair) Sale 3,699 31.32 115,845
2015-06-02 Napolitano Jason A (Chief Financial Officer) Sale 2,464 31.51 77,640
2015-06-02 Grieve Robert B (Executive Chair) Sale 13,301 31.37 417,239
2015-06-01 Napolitano Jason A (Chief Financial Officer) Sale 2,335 31.81 74,276
2015-05-29 Napolitano Jason A (Chief Financial Officer) Sale 5,201 32.47 168,855
2015-05-27 Grieve Robert B (Executive Chair) Sale 1,500 31.00 46,500
2015-05-22 Eyl Steven M. (EVP, Commercial Operations) Sale 2,336 30.07 70,231
2015-05-22 Eyl Steven M. (EVP, Commercial Operations) Option Ex 2,336 7.81 18,244
2015-05-21 Eyl Steven M. (EVP, Commercial Operations) Sale 3,645 30.27 110,337
2015-05-21 Eyl Steven M. (EVP, Commercial Operations) Option Ex 3,645 8.26 30,107
2015-05-18 Riley Sharon L. (Director) Buy 500 29.05 14,525
2015-05-15 Sveen David E. (Director) Option Ex 7,224 9.39 67,833
2015-05-07 Gordon G Irwin (Director) Option Ex 4,000 8.00 32,000
2015-04-24 Grieve Robert B (Executive Chair) Sale 5,000 30.00 150,000
2015-04-22 Grieve Robert B (Executive Chair) Sale 1,000 28.00 28,000
2015-04-13 Grieve Robert B (Executive Chair) Sale 4,000 26.54 106,176
2015-03-09 Wilson Kevin S. (CEO and President) Sale 10,000 25.38 253,780
2015-03-09 Napolitano Jason A (Chief Financial Officer) Sale 5,765 26.02 149,988
2015-03-09 Grieve Robert B (Executive Chair) Sale 2,000 25.26 50,526
2015-03-09 Aylesworth William A (Director) Option Ex 4,571 11.00 50,281
2015-02-03 Grieve Robert B (Executive Chair) Option Ex 28,203 10.33 291,280
2015-02-02 Napolitano Jason A (Chief Financial Officer) Option Ex 19,500 8.80 171,600
2015-01-16 Wisnewski Nancy (EVP, Prod. Dev. & Cust. Supp) Option Ex 6,500 8.80 57,200
2014-11-30 Sveen David E. (Director) Buy 21,428 14.00 299,992
2014-11-30 Wilson Kevin S. (CEO and President) Sale 28,928 14.00 404,992
2014-11-21 Mcginley Michael J (Presi, Biologic. & Pharm.) Sale 9,499 15.45 146,788
2014-11-21 Mcginley Michael J (Presi, Biologic. & Pharm.) Option Ex 9,499 8.80 83,591
2014-11-21 Grieve Robert B (Executive Chair) Sale 1,000 15.54 15,540
2014-11-20 Grieve Robert B (Executive Chair) Sale 2,500 15.30 38,250
2014-11-19 Grieve Robert B (Executive Chair) Sale 3,000 15.12 45,375
2014-11-03 Aylesworth William A (Director) Sale 5,000 13.67 68,355
2014-11-03 Aylesworth William A (Director) Option Ex 5,000 8.60 43,000
2014-08-25 Grieve Robert B (Chief Executive Officer) Sale 1,000 13.40 13,400
2014-08-18 Aylesworth William A (Director) Sale 1,600 13.55 21,680
2014-08-12 Aylesworth William A (Director) Option Ex 5,000 4.60 23,000
2014-08-04 Grieve Robert B (Executive Chair and Director) Sale 12,000 13.53 162,384
2014-07-07 Aylesworth William A (Director) Option Ex 4,200 8.00 33,600
2014-06-05 Grieve Robert B (Executive Chair and Director) Sale 936 10.68 9,991
2014-05-14 Aylesworth William A (Director) Sale 4,200 10.87 45,645
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of HSKA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heska Corp (symbol HSKA, CIK number 1038133) see the Securities and Exchange Commission (SEC) website.